Shenghua Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shenghua Ni has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- David F. Penson
Department of Urology, Vanderbilt University Medical Center, Nashville, TN
12 shared publications Daniel A. Barocas
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
8 shared publicationsAmy J. Graves
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
7 shared publicationsDaniel Barocas
Nashville, TN
7 shared publicationsDavid Penson
Nashville, TN
7 shared publicationsTatsuki Koyama
Nashville, TN
6 shared publications
Latest Publications
- Open Access
- 4 August 2023
- Published by Association for Computing Machinery (ACM)
- p. 5315-5326
PlanRanker: Towards Personalized Ranking of Train Transfer Plans
- 4 August 2023
- Published by Association for Computing Machinery (ACM)
- p. 5315-5326
Open AccessPlanRanker: Towards Personalized Ranking of Train Transfer Plans
- 1 April 2018
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 37 (4) , 467-476
Cardiac rehabilitation and readmissions after heart transplantation
- 1 April 2018
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 37 (4) , 467-476
Cardiac rehabilitation and readmissions after heart transplantation
- 7 March 2017
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (8) , 2101-2108
Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors
AIMS: To identify the prevalence of and risk factors for urinary retention and catheterization among female Medicare beneficiaries.METHODS: We identified women with a diagnosis of urinary retention in a 5% sample of Medicare claims in 2012. Women were categorized into three groups based on the occurrence and duration of urinary catheterization within a 1 year period: 1) no catheterization; 2) short‐term catheterization (ie, one or more catheterizations in less than 30 days); and 3) chronic catheterization (catheterizations in multiple 30 day periods within 1 year). We then identified a group of age‐matched controls without catheterization or a diagnosis of urinary retention in 2012. Clinical and demographic data were collected for each patient, and risk factors for retention and catheterization were compared across groups. We assessed factors associated with urinary retention using multivariable logistic regression.RESULTS: We estimated the rate of retention to be 1532 per 100 000 U.S. female Medicare beneficiaries in 2012, with rates of short term and chronic catheterization estimated to be 160 and 108 per 100 000 women, respectively. Prior diagnoses of neurologic condition, urinary tract infection, and pelvic organ prolapse were positively associated with retention and catheterization in multivariable analyses.CONCLUSIONS: We estimated the prevalence of urinary retention diagnoses among female Medicare beneficiaries to be 1532 per 100 000 women. Retention and catheterization were significantly associated with comorbid disease, with the strongest associations identified with a concomitant diagnosis of neurologic condition, UTI, and POP.
- 7 March 2017
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (8) , 2101-2108
Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors
AIMS: To identify the prevalence of and risk factors for urinary retention and catheterization among female Medicare beneficiaries.METHODS: We identified women with a diagnosis of urinary retention in a 5% sample of Medicare claims in 2012. Women were categorized into three groups based on the occurrence and duration of urinary catheterization within a 1 year period: 1) no catheterization; 2) short‐term catheterization (ie, one or more catheterizations in less than 30 days); and 3) chronic catheterization (catheterizations in multiple 30 day periods within 1 year). We then identified a group of age‐matched controls without catheterization or a diagnosis of urinary retention in 2012. Clinical and demographic data were collected for each patient, and risk factors for retention and catheterization were compared across groups. We assessed factors associated with urinary retention using multivariable logistic regression.RESULTS: We estimated the rate of retention to be 1532 per 100 000 U.S. female Medicare beneficiaries in 2012, with rates of short term and chronic catheterization estimated to be 160 and 108 per 100 000 women, respectively. Prior diagnoses of neurologic condition, urinary tract infection, and pelvic organ prolapse were positively associated with retention and catheterization in multivariable analyses.CONCLUSIONS: We estimated the prevalence of urinary retention diagnoses among female Medicare beneficiaries to be 1532 per 100 000 women. Retention and catheterization were significantly associated with comorbid disease, with the strongest associations identified with a concomitant diagnosis of neurologic condition, UTI, and POP.
- 21 September 2016
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (5) , 1411-1416
Perioperative complications of conduit urinary diversion with concomitant cystectomy for benign indications: A population‐based analysis
Aims Beyond single‐institution case series, limited data are available to describe risks of performing a concurrent cystectomy at the time of urinary diversion for benign end‐stage lower urinary tract dysfunction. Using a population‐representative sample, this study aimed to analyze factors associated with perioperative complications in patients undergoing urinary diversion with or without cystectomy. Methods A representative sample of patients undergoing urinary diversion for benign indications was identified from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample from 1998 to 2011. Perioperative complications of urinary diversion with and without concomitant cystectomy were identified and coded using the International Classification of Diseases, version 9. Multivariate logistic regression models identified hospital and patient‐level characteristics associated with complications of concomitant cystectomy with urinary diversion. Results There were 15,717 records for urinary diversion identified, of which 31.8% demonstrated perioperative complications: urinary diversion with concurrent cystectomy (35.0%) and urinary diversion without concomitant cystectomy (30.6%). Comparing the two groups, a concomitant cystectomy at the time of urinary diversion was significantly associated with a complication (OR = 1.23, 95%CI: 1.03‐1.48). Comorbid conditions of obesity, pulmonary circulation disease, drug abuse, weight loss, and electrolyte disorders were positively associated with a complication, while private insurance and southern geographic region were negatively associated. Conclusions A concomitant cystectomy with urinary diversion for refractory lower urinary tract dysfunction elevates risk in this population‐representative sample, particularly in those with certain comorbid conditions. This analysis provides critical information for preoperative patient counseling.
- 21 September 2016
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (5) , 1411-1416
Perioperative complications of conduit urinary diversion with concomitant cystectomy for benign indications: A population‐based analysis
Aims Beyond single‐institution case series, limited data are available to describe risks of performing a concurrent cystectomy at the time of urinary diversion for benign end‐stage lower urinary tract dysfunction. Using a population‐representative sample, this study aimed to analyze factors associated with perioperative complications in patients undergoing urinary diversion with or without cystectomy. Methods A representative sample of patients undergoing urinary diversion for benign indications was identified from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample from 1998 to 2011. Perioperative complications of urinary diversion with and without concomitant cystectomy were identified and coded using the International Classification of Diseases, version 9. Multivariate logistic regression models identified hospital and patient‐level characteristics associated with complications of concomitant cystectomy with urinary diversion. Results There were 15,717 records for urinary diversion identified, of which 31.8% demonstrated perioperative complications: urinary diversion with concurrent cystectomy (35.0%) and urinary diversion without concomitant cystectomy (30.6%). Comparing the two groups, a concomitant cystectomy at the time of urinary diversion was significantly associated with a complication (OR = 1.23, 95%CI: 1.03‐1.48). Comorbid conditions of obesity, pulmonary circulation disease, drug abuse, weight loss, and electrolyte disorders were positively associated with a complication, while private insurance and southern geographic region were negatively associated. Conclusions A concomitant cystectomy with urinary diversion for refractory lower urinary tract dysfunction elevates risk in this population‐representative sample, particularly in those with certain comorbid conditions. This analysis provides critical information for preoperative patient counseling.
- 27 August 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (1) , 37-43
An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific Survival
Purpose: Followup protocols after the surgical management of renal cell carcinoma lack clear evidence linking the intensity of imaging surveillance to improved outcomes. In this context we characterized the relationship between surveillance imaging intensity and cancer specific survival. Materials and Methods: Using SEER-Medicare data we identified 7,603 men with renal cell carcinoma treated surgically between 2004 and 2009. Multivariable negative binomial regression analysis was performed to assess the relationship between patient level characteristics and the variation in imaging intensity. We modeled the association between kidney cancer specific mortality and imaging intensity using Fine and Gray proportional subdistribution hazards regression with other cause death treated as a competing risk for 2 separate followup periods (15 and 36 months). Results: More than 40% of patients in the short interval cohort and more than 50% in the intermediate interval group underwent no chest imaging during the evaluated survivorship period. More than 30% of patients in both followup periods had no abdominal imaging tests performed. Overall, followup imaging did not appear to confer an improvement in disease specific survival compared to undergoing no imaging in the 2 survivorship periods. Conclusions: There remains considerable variation in the post-treatment surveillance regimen for patients with renal cell carcinoma in the United States. More importantly, this study raises important questions regarding the link between posttreatment surveillance imaging and survival.
- 27 August 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (1) , 37-43
An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific Survival
Purpose: Followup protocols after the surgical management of renal cell carcinoma lack clear evidence linking the intensity of imaging surveillance to improved outcomes. In this context we characterized the relationship between surveillance imaging intensity and cancer specific survival. Materials and Methods: Using SEER-Medicare data we identified 7,603 men with renal cell carcinoma treated surgically between 2004 and 2009. Multivariable negative binomial regression analysis was performed to assess the relationship between patient level characteristics and the variation in imaging intensity. We modeled the association between kidney cancer specific mortality and imaging intensity using Fine and Gray proportional subdistribution hazards regression with other cause death treated as a competing risk for 2 separate followup periods (15 and 36 months). Results: More than 40% of patients in the short interval cohort and more than 50% in the intermediate interval group underwent no chest imaging during the evaluated survivorship period. More than 30% of patients in both followup periods had no abdominal imaging tests performed. Overall, followup imaging did not appear to confer an improvement in disease specific survival compared to undergoing no imaging in the 2 survivorship periods. Conclusions: There remains considerable variation in the post-treatment surveillance regimen for patients with renal cell carcinoma in the United States. More importantly, this study raises important questions regarding the link between posttreatment surveillance imaging and survival.
- Open Access
- 1 April 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (4S)
PD23-11 VARIATION IN EVALUATION OF HEMATURIA BY GENDER, RACE, AND RISK FACTORS FOR BLADDER CANCER
- 1 April 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (4S)
Open AccessPD23-11 VARIATION IN EVALUATION OF HEMATURIA BY GENDER, RACE, AND RISK FACTORS FOR BLADDER CANCER
- 1 March 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (3) , 801-806
Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality
There are growing concerns regarding the overtreatment of localized prostate cancer. It is also relatively unknown whether there has been increased uptake of observational strategies for disease management. We assessed the temporal trend in observation of clinically localized prostate cancer, particularly in men with low risk disease, who were young and healthy enough to undergo treatment. We performed a retrospective cohort study using the SEER-Medicare database in 66,499 men with localized prostate cancer between 2004 and 2009. The main study outcome was observation within 1 year after diagnosis. We performed multivariable analysis to develop a predictive model of observation adjusting for diagnosis year, age, risk and comorbidity. Observation was performed in 12,007 men (18%) with a slight increase with time from 17% to 20%. However, there was marked increase in observation from 18% in 2004 to 29% in 2009 in men with low risk disease. Men 66 to 69 years old with low risk disease and no comorbidities had twice the odds of undergoing observation in 2009 vs 2004 (OR 2.12, 95% CI 1.73-2.59). Age, risk group, comorbidity and race were independent predictors of observation (each p <0.001), in addition to diagnosis year. We identified increasing use of observation for low risk prostate cancer between 2004 and 2009 even in men young and healthy enough for treatment. This suggests growing acceptance of surveillance in this group of patients.
- 1 March 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (3) , 801-806
Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality
There are growing concerns regarding the overtreatment of localized prostate cancer. It is also relatively unknown whether there has been increased uptake of observational strategies for disease management. We assessed the temporal trend in observation of clinically localized prostate cancer, particularly in men with low risk disease, who were young and healthy enough to undergo treatment. We performed a retrospective cohort study using the SEER-Medicare database in 66,499 men with localized prostate cancer between 2004 and 2009. The main study outcome was observation within 1 year after diagnosis. We performed multivariable analysis to develop a predictive model of observation adjusting for diagnosis year, age, risk and comorbidity. Observation was performed in 12,007 men (18%) with a slight increase with time from 17% to 20%. However, there was marked increase in observation from 18% in 2004 to 29% in 2009 in men with low risk disease. Men 66 to 69 years old with low risk disease and no comorbidities had twice the odds of undergoing observation in 2009 vs 2004 (OR 2.12, 95% CI 1.73-2.59). Age, risk group, comorbidity and race were independent predictors of observation (each p <0.001), in addition to diagnosis year. We identified increasing use of observation for low risk prostate cancer between 2004 and 2009 even in men young and healthy enough for treatment. This suggests growing acceptance of surveillance in this group of patients.
- 2 December 2014
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 30 (4) , 440-447
Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries
Female gender and black race are associated with delayed diagnosis and inferior survival in patients with bladder cancer. We aimed to determine the association between gender, race, and evaluation of microscopic hematuria (an early sign of bladder cancer). This was a cohort study using a 5 % random sample of fee-for-service Medicare beneficiaries diagnosed with incident hematuria (International Classification of Diseases, Ninth Revision [ICD-9] code 599.7x) between January 2009 and June 2010 in a primary care setting. Beneficiaries with pre-existing explanatory diagnoses or genitourinary procedures were excluded. The main endpoint was completeness of the hematuria evaluation in the 180 days after diagnosis. Evaluations were categorized as complete, incomplete, or absent based on receipt of relevant diagnostic procedures and imaging studies. In all, 9,211 beneficiaries met the study criteria. Hematuria evaluations were complete in 14 %, incomplete in 21 %, and absent in 65 % of subjects. Compared to males, females were less likely to have a procedure (26 vs. 12 %), imaging (41 vs. 30 %), and a complete evaluation (22 vs. 10 %) (p < 0.001 for each comparison). Receipt of a complete evaluation did not differ by race. Controlling for baseline characteristics, a complete evaluation was less likely in white women (OR, 0.40 [95 % CI, 0.35–0.46]) and black women (OR, 0.46 [95 % CI, 0.29–0.70]) compared to white men; no difference was found between black and white men. Women are less likely than men to undergo a complete and timely hematuria evaluation, a finding likely relevant to women’s more advanced stage at bladder cancer diagnosis. System-level process improvement between providers of urologic and primary care in the evaluation of hematuria may benefit women harboring malignancy.
- 2 December 2014
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 30 (4) , 440-447
Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries
Female gender and black race are associated with delayed diagnosis and inferior survival in patients with bladder cancer. We aimed to determine the association between gender, race, and evaluation of microscopic hematuria (an early sign of bladder cancer). This was a cohort study using a 5 % random sample of fee-for-service Medicare beneficiaries diagnosed with incident hematuria (International Classification of Diseases, Ninth Revision [ICD-9] code 599.7x) between January 2009 and June 2010 in a primary care setting. Beneficiaries with pre-existing explanatory diagnoses or genitourinary procedures were excluded. The main endpoint was completeness of the hematuria evaluation in the 180 days after diagnosis. Evaluations were categorized as complete, incomplete, or absent based on receipt of relevant diagnostic procedures and imaging studies. In all, 9,211 beneficiaries met the study criteria. Hematuria evaluations were complete in 14 %, incomplete in 21 %, and absent in 65 % of subjects. Compared to males, females were less likely to have a procedure (26 vs. 12 %), imaging (41 vs. 30 %), and a complete evaluation (22 vs. 10 %) (p < 0.001 for each comparison). Receipt of a complete evaluation did not differ by race. Controlling for baseline characteristics, a complete evaluation was less likely in white women (OR, 0.40 [95 % CI, 0.35–0.46]) and black women (OR, 0.46 [95 % CI, 0.29–0.70]) compared to white men; no difference was found between black and white men. Women are less likely than men to undergo a complete and timely hematuria evaluation, a finding likely relevant to women’s more advanced stage at bladder cancer diagnosis. System-level process improvement between providers of urologic and primary care in the evaluation of hematuria may benefit women harboring malignancy.